Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Allotera Therapeutics
Business Services · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4260 Forest Park Ave Ste 100, Saint Loui...Phone Number
(636) 385-5306Website
www.alloteratx.comRevenue
$10.6 MillionIndustry
About Allotera Therapeutics
Allotera Therapeutics is a clinical-stage biotechnology company developing off-the-shelf allogeneic CAR-T cell therapies for the treatment of cancer and autoimmune diseases. Its pipeline includes programs targeting T-cell malignancies, acute myeloid leukemia (AML), and autoimmune disorders using proprietary allogeneic T-cell platforms. The company is advancing multiple clinical and preclinical candidates designed to improve the accessibility, scalability, and effectiveness of cell therapies.Explore more
Allotera Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allotera Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Allotera Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Allotera Therapeutics has new funding data
Allotera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Allotera Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Allotera Therapeutics recently announced quarterly report
Product Launch: Get notified when Allotera Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Allotera Therapeutics
Website visits: Recent activity has been detected on your website
Check out if Allotera Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Allotera Therapeutics
Find 3 more new buyers
Allotera Therapeutics financials insights
Gather financial insights about Allotera Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Debt
$35M
Frequently Asked Questions Regarding Allotera Therapeutics
Sign Up For FreeTo access detailed company insights
Allotera Therapeutics is a clinical-stage biotechnology company developing off-the-shelf allogeneic CAR-T cell therapies for the treatment of cancer and autoimmune diseases. Its pipeline includes programs targeting T-cell malignancies, acute myeloid leukemia (AML), and autoimmune disorders using proprietary allogeneic T-cell platforms. The company... Read More
